Petlife Pharmaceuticals, Inc.
PTLF
$0.0001
$0.000.00%
| 02/28/2018 | 11/30/2017 | 08/31/2017 | 05/31/2017 | 02/28/2017 | |
|---|---|---|---|---|---|
| Net Income | -3.71M | -4.61M | -23.26M | -24.58M | -23.89M |
| Total Depreciation and Amortization | -- | -- | -- | -- | -- |
| Total Amortization of Deferred Charges | 98.80K | 85.70K | 8.70K | 87.50K | 50.00K |
| Total Other Non-Cash Items | 2.93M | 4.53M | 22.48M | 21.31M | 20.68M |
| Change in Net Operating Assets | 422.40K | -267.50K | 452.80K | 2.60M | 2.67M |
| Cash from Operations | -261.90K | -256.30K | -318.90K | -585.00K | -491.20K |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | 338.20K | 331.50K | 406.90K | 615.20K | 491.70K |
| Total Debt Repaid | -68.80K | -49.80K | -34.80K | -29.80K | -- |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 269.40K | 281.70K | 372.10K | 585.40K | 491.70K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 7.40K | 25.30K | 53.00K | 300.00 | 400.00 |
